Abstract: Poster Presentations |

Extracorporeal Life Support (ECLS) for ARDS Caused by Severe Pneumonitis FREE TO VIEW

Robert H. Bartlett, MD*; Mark R. Hemmila, MD; Fresca C. Swaniker, MD; Jonathan W. Haft, MD; Ronald B. Hirschl, MD; Stephen A. Rowe, MD
Author and Funding Information

University of Michigan Medical Center, Ann Arbor, MI


Chest. 2004;126(4_MeetingAbstracts):875S. doi:10.1378/chest.126.4_MeetingAbstracts.875S
Text Size: A A A
Published online


PURPOSE:  To report a single center experience with ECLS for severe ARDS pathophysiology caused by pneumonitis.

METHODS:  ECLS (ECMO) supports cardiac and pulmonary function in the absence of native organ function allowing time for treatment of primary pulmonary disease. Between 1990 and 2003 we treated 132 moribund patients with ECLS. Patient characteristics AaDO2 612, shunt fraction 55%, P/F rtio 54, all despite and after optimal treatment (3.8 ventilator days). Average time on ECLS was 9 days. Septic shock and multiple-organ failure were common complications.

RESULTS:  The cause of pneumonia, numbers of patients, and hospital discharge survival was: bacterial N79, 57%; viral N33, 55%; aspiration N13, 62%; fungal N7, 29%; overall cases N132, 55% survival.

CONCLUSION:  Extracorporeal life support resulted in recovery and survival in 55% of 132 patients with overwhelming pneumonitis.

CLINICAL IMPLICATIONS:  ECLS should be considered in patients with high mortality risk from pneumonitis.

DISCLOSURE:  R.H. Bartlett, None.

Wednesday, October 27, 2004

12:30 PM- 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543